NASDAQ:XFOR | Free Cash Flow | X4 Pharmaceuticals, Inc

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2016-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$19.6M
2025-12-31-$15.53M
2025-03-31-$12.37M
2024-12-31-$33M
2024-06-30-$63.9M
2024-03-31-$33.6M
2023-12-31-$27.75M
2023-09-30-$68.8M
2023-06-30-$47.9M
2023-03-31-$26.51M
2022-12-31-$19.09M
2022-03-31-$20.23M
2021-12-31-$19.05M
2021-03-31-$18.44M
2020-12-31-$17.5M
2020-03-31-$15.53M
2019-12-31-$9.24M
2019-03-31-$11.75M
2018-12-31-$6.73M
2018-03-31-$6.18M
2017-12-31-$6.35M
2017-03-31-$3.51M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$85.62M
2024-12-31-$130.9M$326,000.00-$131.23M
2023-12-31-$96.51M$60,000.00-$96.57M
2022-12-31-$77.1M$103,000.00-$77.21M
2021-12-31-$70.91M
2020-12-31-$58.82M
2019-12-31-$48.06M
2018-12-31-$25.42M
2017-12-31-$21.31M
2016-12-31-$21.64M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.